Comment on "Somatostatin as Inflow Modulator in Liver-transplant Recipients With Severe Portal Hypertension: A Randomized Trial"

Affiliation

• ¹ CHESS Frontier Center, The First Hospital of Lanzhou University, Lanzhou, China The First School of Clinical Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China School of Public Health, Southern Medical University, Guangzhou, China The Fifth Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, China CHESS Frontier Center, The First Hospital of Lanzhou University, Lanzhou, China.